Eli Lilly sues the US government over its proposed 340B rebate model
Eli Lilly is now the second drugmaker to propose a rebate model for 340B drug price discounts — and the second to sue over it. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
